Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
November-2017 Volume 38 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 38 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism

  • Authors:
    • Wen-Qing Gao
    • Jing Ma
    • Liu-Liu Sun
    • Qi Li
    • Rui-Yu Zhu
    • Jian Jin
  • View Affiliations / Copyright

    Affiliations: Laboratory of Molecular Pharmacology, School of Pharmaceutical Sciences, Jiangnan University, Wuxi, Jiangsu 214122, P.R. China
  • Pages: 3211-3219
    |
    Published online on: September 18, 2017
       https://doi.org/10.3892/or.2017.5958
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that is best known in mediating the toxicities of dioxins and dioxin-like compounds. AHR is activated by a variety of endogenous ligands and participating in tumor development. Thus, it will provide a new approach for cancer prevention and treatment to study the translation mechanism of AHR in tumor cells. In this study, we show that the 5'-untranslated region (UTR) of AHR mRNA contains an internal ribosome entry site (IRES). After mapping the entire AHR 5'-UTR, we determined that the full-length 5'-UTR is indispensable for the highest IRES activity. Interestingly, we found that AHR expression is induced in ovarian (A2780), breast (MDA-MB231), hepatic (Bel7402) and colorectal cancer cells (SW620) by chemotherapeutic drug paclitaxel (PTX) through IRES-dependent translation mechanism. Moreover, IRES activity is increased in the PTX-resistant ovarian cancer cells in which AHR protein expression was also enhanced. These results strongly suggest an important role for AHR IRES-dependent translation mechanism in cancer cell response to paclitaxel treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Tian J, Feng Y, Fu H, Xie HQ, Jiang JX and Zhao B: The aryl hydrocarbon receptor: A key bridging molecule of external and internal chemical signals. Environ Sci Technol. 49:9518–9531. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Beischlag TV, Morales J Luis, Hollingshead BD and Perdew GH: The aryl hydrocarbon receptor complex and the control of gene expression. Crit Rev Eukaryot Gene Expr. 18:207–250. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Safe S and Krishnan V: Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. Arch Toxicol (Suppl). 17:99–115. 1995. View Article : Google Scholar : PubMed/NCBI

4 

Hanieh H: Toward understanding the role of aryl hydrocarbon receptor in the immune system: Current progress and future trends. BioMed Res Int. 2014:5207632014. View Article : Google Scholar : PubMed/NCBI

5 

Gonzalez FJ and Fernandez-Salguero P: The aryl hydrocarbon receptor: Studies using the AHR-null mice. Drug Metab Dispos. 26:1194–1198. 1998.PubMed/NCBI

6 

Schmidt JV, Su GH, Reddy JK, Simon MC and Bradfield CA: Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA. 93:pp. 6731–6736. 1996; View Article : Google Scholar : PubMed/NCBI

7 

Lahvis GP, Lindell SL, Thomas RS, McCuskey RS, Murphy C, Glover E, Bentz M, Southard J and Bradfield CA: Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. Proc Natl Acad Sci USA. 97:pp. 10442–10447. 2000; View Article : Google Scholar : PubMed/NCBI

8 

Lahvis GP, Pyzalski RW, Glover E, Pitot HC, McElwee MK and Bradfield CA: The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol Pharmacol. 67:714–720. 2005. View Article : Google Scholar : PubMed/NCBI

9 

Gasiewicz TA, Singh KP and Casado FL: The aryl hydrocarbon receptor has an important role in the regulation of hematopoiesis: Implications for benzene-induced hematopoietic toxicity. Chem Biol Interact. 184:246–251. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Mulero-Navarro S and Fernandez-Salguero PM: New trends in aryl hydrocarbon receptor biology. Front Cell Dev Biol. 4:452016. View Article : Google Scholar : PubMed/NCBI

11 

Salisbury TB and Tomblin JK: Insulin/insulin-like growth factors in cancer: New roles for the aryl hydrocarbon receptor, tumor resistance mechanisms, and new blocking strategies. Front Endocrinol (Lausanne). 6:122015.PubMed/NCBI

12 

Feng S, Cao Z and Wang X: Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta. 1836:197–210. 2013.PubMed/NCBI

13 

Wang LT, Chiou SS, Chai CY, Hsi E, Wang SN, Huang SK and Hsu SH: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma. Oncotarget. 8:7489–7501. 2017.PubMed/NCBI

14 

Stanford EA, Wang Z, Novikov O, Mulas F, Landesman-Bollag E, Monti S, Smith BW, Seldin DC, Murphy GJ and Sherr DH: The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem-like cells. BMC Biol. 14:202016. View Article : Google Scholar : PubMed/NCBI

15 

Li EY, Huang WY, Chang YC, Tsai MH, Chuang EY, Kuok QY, Bai ST, Chao LY, Sher YP and Lai LC: Aryl hydrocarbon receptor activates NDRG1 transcription under hypoxia in breast cancer cells. Sci Rep. 6:208082016. View Article : Google Scholar : PubMed/NCBI

16 

Li ZD, Wang K, Yang XW, Zhuang ZG, Wang JJ and Tong XW: Expression of aryl hydrocarbon receptor in relation to p53 status and clinicopathological parameters in breast cancer. Int J Clin Exp Pathol. 7:7931–7937. 2014.PubMed/NCBI

17 

Chang CY and Puga A: Constitutive activation of the aromatic hydrocarbon receptor. Mol Cell Biol. 18:525–535. 1998. View Article : Google Scholar : PubMed/NCBI

18 

Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, et al: An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature. 478:197–203. 2011. View Article : Google Scholar : PubMed/NCBI

19 

Hinnebusch AG and Lorsch JR: The mechanism of eukaryotic translation initiation: new insights and challenges. Cold Spring Harb Perspect Biol. July 18–2012.(Epub ahead of print). doi: 10.1101/cshperspect.a011544. View Article : Google Scholar : PubMed/NCBI

20 

Shatsky IN, Dmitriev SE, Terenin IM and Andreev DE: Cap- and IRES-independent scanning mechanism of translation initiation as an alternative to the concept of cellular IRESs. Mol Cells. 30:285–293. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Komar AA and Hatzoglou M: Cellular IRES-mediated translation: The war of ITAFs in pathophysiological states. Cell Cycle. 10:229–240. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Jang SK, Kräusslich HG, Nicklin MJ, Duke GM, Palmenberg AC and Wimmer E: A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol. 62:2636–2643. 1988.PubMed/NCBI

23 

Pelletier J and Sonenberg N: Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature. 334:320–325. 1988. View Article : Google Scholar : PubMed/NCBI

24 

Holcik M, Lefebvre C, Yeh C, Chow T and Korneluk RG: A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol. 1:190–192. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Subkhankulova T, Mitchell SA and Willis AE: Internal ribosome entry segment-mediated initiation of c-Myc protein synthesis following genotoxic stress. Biochem J. 359:183–192. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Dobson T, Chen J and Krushel LA: Dysregulating IRES-dependent translation contributes to overexpression of oncogenic Aurora A kinase. Mol Cancer Res. 11:887–900. 2013. View Article : Google Scholar : PubMed/NCBI

27 

Gonzalez-Herrera IG, Prado-Lourenco L, Pileur F, Conte C, Morin A, Cabon F, Prats H, Vagner S, Bayard F, Audigier S, et al: Testosterone regulates FGF-2 expression during testis maturation by an IRES-dependent translational mechanism. FASEB J. 20:476–478. 2006.PubMed/NCBI

28 

Pedersen SK, Christiansen J, Hansen T, Larsen MR and Nielsen FC: Human insulin-like growth factor II leader 2 mediates internal initiation of translation. Biochem J. 363:37–44. 2002. View Article : Google Scholar : PubMed/NCBI

29 

Rubtsova MP, Sizova DV, Dmitriev SE, Ivanov DS, Prassolov VS and Shatsky IN: Distinctive properties of the 5′-untranslated region of human hsp70 mRNA. J Biol Chem. 278:22350–22356. 2003. View Article : Google Scholar : PubMed/NCBI

30 

Oumard A, Hennecke M, Hauser H and Nourbakhsh M: Translation of NRF mRNA is mediated by highly efficient internal ribosome entry. Mol Cell Biol. 20:2755–2759. 2000. View Article : Google Scholar : PubMed/NCBI

31 

Gao W, Li Q, Zhu R and Jin J: La autoantigen induces ribosome binding protein 1 (RRBP1) expression through internal ribosome entry site (IRES)-mediated translation during cellular stress condition. Int J Mol Sci. 17:11742016. View Article : Google Scholar :

32 

Dai W, Ma W, Li Q, Tao Y, Ding P, Zhu R and Jin J: The 5′-UTR of DDB2 harbors an IRES element and upregulates translation during stress conditions. Gene. 573:57–63. 2015. View Article : Google Scholar : PubMed/NCBI

33 

Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Liu W, Qiang B, et al: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med (Berl). 87:43–51. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Fujisawa Y, Li W, Wu D, Wong P, Vogel C, Dong B, Kung HJ and Matsumura F: Ligand-independent activation of the arylhydrocarbon receptor by ETK (Bmx) tyrosine kinase helps MCF10AT1 breast cancer cells to survive in an apoptosis-inducing environment. Biol Chem. 392:897–908. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Yin J, Sheng B, Qiu Y, Yang K, Xiao W and Yang H: Role of AhR in positive regulation of cell proliferation and survival. Cell Prolif. 49:554–560. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Morales-Hernández A, González-Rico FJ, Román AC, Rico-Leo E, Alvarez-Barrientos A, Sánchez L, Macia Á, Heras SR, García-Pérez JL, Merino JM, et al: Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor. Nucleic Acids Res. 44:4665–4683. 2016. View Article : Google Scholar : PubMed/NCBI

37 

Wang K, Li Y, Jiang YZ, Dai CF, Patankar MS, Song JS and Zheng J: An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cells. Cancer Lett. 340:63–71. 2013. View Article : Google Scholar : PubMed/NCBI

38 

Martínez-Salas E, Lozano G, Fernandez-Chamorro J, Francisco-Velilla R, Galan A and Diaz R: RNA-binding proteins impacting on internal initiation of translation. Int J Mol Sci. 14:21705–21726. 2013. View Article : Google Scholar : PubMed/NCBI

39 

Costa-Mattioli M, Svitkin Y and Sonenberg N: La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol. 24:6861–6870. 2004. View Article : Google Scholar : PubMed/NCBI

40 

Cobbold LC, Wilson LA, Sawicka K, King HA, Kondrashov AV, Spriggs KA, Bushell M and Willis AE: Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1. Oncogene. 29:2884–2891. 2010. View Article : Google Scholar : PubMed/NCBI

41 

Cobbold LC, Spriggs KA, Haines SJ, Dobbyn HC, Hayes C, de Moor CH, Lilley KS, Bushell M and Willis AE: Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol. 28:40–49. 2008. View Article : Google Scholar : PubMed/NCBI

42 

Yang L, Gu L, Li Z and Zhou M: Translation of TRAF1 is regulated by IRES-dependent mechanism and stimulated by vincristine. Nucleic Acids Res. 38:4503–4513. 2010. View Article : Google Scholar : PubMed/NCBI

43 

Zhang X, Richie C and Legerski RJ: Translation of hSNM1 is mediated by an internal ribosome entry site that upregulates expression during mitosis. DNA Repair (Amst). 1:379–390. 2002.PubMed/NCBI

44 

Van Eden ME, Byrd MP, Sherrill KW and Lloyd RE: Translation of cellular inhibitor of apoptosis protein 1 (c-IAP1) mRNA is IRES mediated and regulated during cell stress. RNA. 10:469–481. 2004. View Article : Google Scholar : PubMed/NCBI

45 

Gardella KA, Muro I, Fang G, Sarkar K, Mendez O and Wright CW: Aryl hydrocarbon receptor nuclear translocator (ARNT) isoforms control lymphoid cancer cell proliferation through differentially regulating tumor suppressor p53 activity. Oncotarget. 7:10710–10722. 2016. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Gao W, Ma J, Sun L, Li Q, Zhu R and Jin J: Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism. Oncol Rep 38: 3211-3219, 2017.
APA
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., & Jin, J. (2017). Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism. Oncology Reports, 38, 3211-3219. https://doi.org/10.3892/or.2017.5958
MLA
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., Jin, J."Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism". Oncology Reports 38.5 (2017): 3211-3219.
Chicago
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., Jin, J."Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism". Oncology Reports 38, no. 5 (2017): 3211-3219. https://doi.org/10.3892/or.2017.5958
Copy and paste a formatted citation
x
Spandidos Publications style
Gao W, Ma J, Sun L, Li Q, Zhu R and Jin J: Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism. Oncol Rep 38: 3211-3219, 2017.
APA
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., & Jin, J. (2017). Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism. Oncology Reports, 38, 3211-3219. https://doi.org/10.3892/or.2017.5958
MLA
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., Jin, J."Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism". Oncology Reports 38.5 (2017): 3211-3219.
Chicago
Gao, W., Ma, J., Sun, L., Li, Q., Zhu, R., Jin, J."Paclitaxel-mediated human aryl hydrocarbon receptor mRNA translation by an internal ribosomal entry site-dependent mechanism". Oncology Reports 38, no. 5 (2017): 3211-3219. https://doi.org/10.3892/or.2017.5958
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team